Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-79.83	36.90	-182.97
Graham Fair Price	-6.69	35.44	37.98
PEG	40.46	-1.61	-2.71
Price/Book	-10.70	1.26	1.41
Price/Cash Flow	29.38	-14.52	-20.56
Prices/Earnings	8.08	23.93	22.14
Price/Sales	-4.83	7.16	7.53
Price/FCF	29.38	-14.52	-20.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	192.26	0.20	0.07
Operating Margin	-55.03	0.09	-0.20
ROA	-17.49	< 0.005	< 0.005
ROE	0.02	0.01	-17.38
ROIC	-0.02	< 0.005	-60.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	< 0.005	825.79
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.55	1.43	-43.74
EPS QOQ	-0.08	-0.15	-81.52
FCF QOQ	0.42	-0.30	-28.27
Revenue QOQ	0.02	-0.04	70.99
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	81.62	101.19	23.99
Days Sales Outstanding (DSO)	58.58	58.56	-0.03
Inventory Turnover	1.10	0.89	-19.35
Debt/Capitalization	0.32	0.30	-5.54
Quick Ratio	1.09	0.97	-11.05
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	63.48	65.17	2.66
Cash	15.45	12.27	-20.59
Capex	-9.80	-7.70	21.49
Free Cash Flow	-4.35	-5.65	-29.81
Revenue	11.89	11.45	-3.67
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.58	1.60	1.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-29.62	8.26	-72.12
Naive Interpretation	Member

06 - Financial Health · Weak

Rating